AppLovin Corporation

(NASDAQ Global Select)
Slightly Bearish -20

AppLovin Just Dropped 12% in a Month. Is It Time to Sell, or Load Up?

📉 AppLovin stock fell 12.6% through October 19 as advertising growth concerns, litigation risks, and analyst price-target cuts weighed on sentiment.

💰 The company reported Q2 revenue of $1.924 billion, up 53% year over year, though slightly below the $1.94 billion consensus estimate.

🤖 CEO Adam Foroughi acknowledged weaker-than-usual improvements in the company's AI-driven advertising models during the second quarter.

⚖️ AppLovin faces securities class-action allegations regarding its AI technology and an ongoing legal dispute with Unity Software (U).

📉 Seven investment firms reduced their price targets between October 8 and 19, while five maintained Buy-equivalent ratings.

📊 The average analyst price target declined from approximately $744 in January to around $477, yet remains above the current stock price.

📉 APP recently traded at 14x forward earnings, significantly below its five-year average of 25.6x.

🔮 TIKR consensus estimates project normalized EPS rising from $10.64 in 2025 to approximately $21 by 2027.

📅 AppLovin expects third-quarter revenue between $2.055 billion and $2.085 billion with adjusted EBITDA guidance of $1.710 billion to $1.740 billion.

🗓️ The company will report its Q3 results on November 4, after the market closes.

Bullish Signals
  • AppLovin reported second-quarter revenue of $1.924 billion, representing a robust 53% year-over-year increase despite missing analyst expectations.
  • Five major investment firms maintained Buy-equivalent ratings for the company between October 8 and October 19, indicating cautious optimism.
  • The consensus analyst price target remains substantially above the current trading price of $269.12, suggesting meaningful potential upside.
  • Long-term earnings expectations remain strong, with projections showing normalized EPS rising from $10.64 in 2025 to approximately $21 by 2027.
Risk Factors
  • AppLovin stock fell 12.6% through October 19 as concerns about AI-model improvements and litigation weighed on investor sentiment.
  • Seven investment firms reduced their price targets between October 8 and October 19, with Jefferies lowering its target from $550 to $375.
  • The company faces securities class-action allegations involving its AI technology and an ongoing legal dispute with Unity Software (U).
  • AppLovin's Q2 revenue of $1.924 billion was slightly below analysts' expectations of $1.94 billion, reflecting weaker-than-usual model improvements.
  • The company currently trades at 14x forward earnings, which is approximately 56% of its historical five-year average valuation multiple.
Full Analysis
AppLovin (APP) shares declined 12.6% through October 19, underperforming the S&P 500 as concerns regarding AI model improvements, ongoing litigation, and reduced analyst price targets weighed on investor sentiment. Despite the stock price drop, consensus earnings estimates have remained relatively stable, suggesting that much of the decline may be driven by valuation compression rather than a fundamental deterioration in growth expectations. The company reported second-quarter revenue of $1.924 billion, representing a 53% year-over-year increase, though this figure missed analyst expectations of $1.94 billion. CEO Adam Foroughi acknowledged weaker-than-usual improvements in the AI-driven advertising models during the quarter. Concurrently, AppLovin faces securities class-action allegations involving its AI technology and an ongoing legal dispute with Unity Software (U). Analyst sentiment remains mixed but cautiously optimistic; seven firms lowered their price targets between October 8 and 19, while five maintained Buy-equivalent ratings. The average analyst price target dropped from approximately $744 in January to around $477, yet the consensus target still sits substantially above the current trading price of roughly $269. Valuation multiples have contracted significantly, with APP trading at 14x forward earnings compared to a five-year average of 25.6x.